Revenue
attach_money1,912,323M JPY
YoY +19.2%
ALPMYAstellas Pharma Inc.$ --
Astellas Pharma Inc.
ALPMY
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 03/31/2025
Operating Income
bar_chart41,039M JPY
YoY +60.8%
Net Income
verified50,747M JPY
YoY +197.7%
EPS
pie_chart28.35JPY
YoY +198.1%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress99.7%On Track
Revenue Progress1.6T
Revenue Forecast2.1T
Net Income Progress251.2B
Net Income Forecast251.8B
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.